Patient Guide: A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 49 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05630755
Status: ACTIVE_NOT_RECRUITING
Condition: HIV-1 Infection
Phase: PHASE3

Where You Can Participate

This study is available at 49 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Beverly Hills, California
  • • Los Angeles, California
  • • And 46 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052) - Join Clinical Trial NCTNCT05630755

How to Join This Clinical Trial - NCTNCT05630755

Learn how to participate in this PHASE3 trial studying an investigational therapy for HIV-1 Infection. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HIV-1 Infection. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HIV-1 Infection
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05630755 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 49 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85015 - United States

Status: Contact for availability

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90036 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90069 - United States

Status: Contact for availability

Clinical Research Site

Washington, District of Columbia 20005 - United States

Status: Contact for availability

Clinical Research Site

Fort Lauderdale, Florida 33308 - United States

Status: Contact for availability

Clinical Research Site

Fort Pierce, Florida 34982 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33133 - United States

Status: Contact for availability

Clinical Research Site

Orlando, Florida 32803 - United States

Status: Contact for availability

Clinical Research Site

West Palm Beach, Florida 33407 - United States

Status: Contact for availability

And 39 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for HIV-1 Infection:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships